SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : SARS - what next?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Maurice Winn who wrote (812)12/29/2003 10:38:34 AM
From: Henry Niman   of 1070
 
The report in today's WSJ that the current Guangzhou case was a suspect SARS case in March, points to the importance of reliable data from the first outbreak, which unfortunately has been subject to significant manipulation (like the 36 deaths in Taiwan who were SARS CoV positive but were removed from the Taiwan SARS total because they were said to have had underlying disease - which was not fully supported by Taiwan's own web site, yet have been removed from the WHO totals).

However, science can overcome these manipulations with sequence data. The sequences out of Guangzhou were from some early (late Jan/ early Feb cases) and this data can shed some light on the origin of the current infection. If it matches the earlier sequences (heavily mutated with 29 nt deletion), then the chance that the virus persisted at a low level in this patient is increased.

The reported rising antibody titer would indicate that the current infection is recent.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News